Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT00654160What this trial is testingIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerWho this might be right forAnal CancerCarcinoma of the AppendixColorectal Cancer+9 more Mayo Clinic 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623642What this trial is testingA Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.Who this might be right forUterine Cervical NeoplasmsTriple Negative Breast NeoplasmsProstatic Neoplasms+8 more GV20 Therapeutics 227
Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05039892What this trial is testingEfficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic CholangiocarcinomaWho this might be right forCholangiocarcinoma,Adult 3D Medicines (Beijing) Co., Ltd. 50
Not applicableStudy completedNCT03796819What this trial is testingRoutine Lymphadenectomy for Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic Cholangiocarcinoma First Affiliated Hospital Xi'an Jiaotong University 260
Testing effectiveness (Phase 2)WithdrawnNCT00386516What this trial is testingStudy to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder CancerWho this might be right forCancer of the Bile DuctGallbladder Cancer Galectin Therapeutics Inc.
Not applicableStudy completedNCT05461430What this trial is testingMass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)Who this might be right forPleural Effusion, MalignantAscites, MalignantCarcinoma+29 more Travera Inc 72
Large-scale testing (Phase 3)Ended earlyNCT03656536What this trial is testingEvaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic CholangiocarcinomaWho this might be right forUnresectable CholangiocarcinomaMetastatic Cholangiocarcinoma Incyte Corporation 167
Testing effectiveness (Phase 2)Study completedNCT00059865What this trial is testingGemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer Alliance for Clinical Trials in Oncology 68
Testing effectiveness (Phase 2)Study completedNCT00789958What this trial is testingS0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile DuctWho this might be right forExtrahepatic Bile Duct CancerGallbladder Cancer SWOG Cancer Research Network 105
Early research (Phase 1)Active Not RecruitingNCT05215574What this trial is testingStudy of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid TumorsWho this might be right forPancreatic CancerBreast CancerGastric Cancer+13 more NGM Biopharmaceuticals, Inc 130
Testing effectiveness (Phase 2)Ended earlyNCT01855724What this trial is testingClinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree CancerWho this might be right forCholangiocarcinomaGallbladder CarcinomaBiliary Carcinoma Hellenic Cooperative Oncology Group 29
Testing effectiveness (Phase 2)WithdrawnNCT06690281What this trial is testingA Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal MalignanciesWho this might be right forGastrointestinal CarcinomaPancreatic CancerHepatocellular Cancer+5 more National Cancer Institute (NCI)
Not applicableNot Yet RecruitingNCT07707661What this trial is testingApplication of Super-Resolution Ultrasound (SRUS) in Liver TumorWho this might be right forHepatocellular Carcinoma (HCC)Intrahepatic Cholangiocellular CarcinomaHepatic Hemangioma+2 more Eastern Hepatobiliary Surgery Hospital 350
Early research (Phase 1)Ended earlyNCT02626312What this trial is testingRadiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver FunctionWho this might be right forCholangiocarcinomaCirrhosisHepatocellular Carcinoma+1 more M.D. Anderson Cancer Center 36
Not applicableUnknownNCT02103179What this trial is testingVEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC)Who this might be right forExtrahepatic Cholangiocarcinoma First Affiliated Hospital, Sun Yat-Sen University 20
Testing effectiveness (Phase 2)UnknownNCT06134193What this trial is testingCombination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract CancerWho this might be right forCarcinomaIntrahepatic CholangiocarcinomaGallbladder Cancer+5 more Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876What this trial is testingEfficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsWho this might be right forMSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more SOLTI Breast Cancer Research Group 184
Early research (Phase 1)Study completedNCT00002854What this trial is testingHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerWho this might be right forCancer City of Hope Medical Center 33